Tools chosen: kalshi_direct fred claude_news code_execution kalshi_related polymarket_related

Sub-questions (Fermi decomposition)

Planner reasoning

This resolves Yes if quarterly federal expenditures (FGEXPND) fall at least $250B below Q4 2024 levels in any quarter through Q4 2028. Federal spending has trended upward for decades, so I need the Q4 2024 baseline, recent FGEXPND trajectory, and any policy signals (DOGE cuts, shutdowns, budget deals) that could force a sharp drop. Market price anchors the consensus.

# Current state FGEXPND (federal government current expenditures, SAAR) was $7,247.7B in Q4 2024 per FRED. The resolution criterion requires any quarter through Q4 2028 to show FGEXPND ≤ $6,997.7B (i.e., $250B below Q4 2024). As of Q1 2026 (latest FRED observation), spending is $7,679.7B — $432B *above* baseline, moving in the wrong direction. # Timeline of key events - **2024-10-01**: Q4 2024 FGEXPND = $7,247.7B (FRED) — confirmed baseline - **2025-01-01**: Q1 2025 FGEXPND = $7,313.6B (+$66B vs baseline) — confirmed - **2025-04-01**: Q2 2025 FGEXPND = $7,496.3B (+$249B vs baseline) — confirmed - **2025-07-04**: "One Big Beautiful Bill Act" (OBBBA) signed — confirmed; CBO projects $840B Medicaid cuts over 10 years, but work requirements don't begin until Dec 2026 - **2025-07-01**: Q3 2025 FGEXPND = $7,580.2B (+$333B vs baseline) — confirmed - **2025-10-01**: Q4 2025 FGEXPND = $7,583.7B (+$336B vs baseline) — confirmed - **2026-01-01**: Q1 2026 FGEXPND = $7,679.7B (+$432B vs baseline) — confirmed - **2026-07-04**: DOGE officially ended — confirmed; "didn't work out" per Fiscal Times --- # Event Will FGEXPND fall ≥$250B below Q4 2024 level ($7,247.7B) in any quarter through Q4 2028? # Outcomes to forecast - **Yes** (FGEXPND ≤ $6,997.7B in any quarter Q1 2025–Q4 2028) - **No** # Kalshi market anchor **Current YES price: 13.00%** | 7-day change: +8.5% | 30-day change: +5.4% | Avg daily volume: 81 contracts | Range (25 days): 4.5%–17.0%. Recent sharp upward move (+8.5% in 7 days) suggests some new bullish signal, but market remains heavily "No"-leaning. # Sub-question answers 1. **Q4 2024 FGEXPND level?** — $7,247.7B SAAR (FRED, confirmed). The code_execution tool used an approximate value of $6,720B; the FRED primary data supersedes this estimate. 2. **Most recent quarterly FGEXPND and trend?** — Q1 2026: $7,679.7B, up $432B from Q4 2024 baseline (FRED). Every quarter since Q4 2024 has risen; trend is firmly upward. 3. **Historical precedent for $250B+ drop within 3 years?** — Never occurred outside COVID-era shocks (FRED historical data). Largest non-COVID QoQ drop was ~$194B (2022 post-stimulus). Monte Carlo baseline probability: ~1.7% (code_execution). 4. **Credible policy actions to cut $250B in a quarter?** — DOGE ended July 4, 2026 with disputed savings (~$85-150B claimed, far less verified; Cato/Wikipedia). OBBBA Medicaid cuts ramp post-2027. No single mechanism credibly delivers $250B absolute quarterly reduction before 2028 vs. baseline; mandatory spending growth (~$150-200B/year) offsets discretionary cuts (Cato). 5. **Kalshi price?** — 13.00% YES (Kalshi direct). # Key facts (high-confidence, factual) 1. [FRED] Q4 2024 FGEXPND = $7,247.7B SAAR; resolution threshold = $6,997.7B 2. [FRED] Q1 2026 FGEXPND = $7,679.7B — $432B *above* baseline, not below 3. [CRFB] Federal spending was $142B higher H1 2025 vs H1 2024 4. [Cato] Every month of 2025 spending exceeded same month of any prior year; no structural break from DOGE 5. [Wikipedia/Cato] DOGE claimed ~$150B cuts (disputed); verified outlay impact far smaller; DOGE ended July 2026 6. [USAFacts] OBBBA Medicaid work requirements begin Dec 2026; bulk of $840B savings is post-2027 7. [code_execution] Monte Carlo baseline: ~1.7% probability; aggressive-cut scenario: ~74% — outcome is nearly entirely scenario-dependent # Cross-market signals - **Kalshi related**: Only this market directly tracks FGEXPND cuts; no corroborating sister markets - **Polymarket**: No matching markets found - **Sportsbook implied**: N/A # Analyst opinions and speculation - Cato Institute: Workforce cuts cannot meaningfully reduce outlays since ~70%+ is transfer payments; 10% workforce cut ≈ only $40B/year savings - CBO: OBBBA adds ≥$3.4T to debt despite spending cuts — net fiscal effect is expansionary - Code_execution model: Required ~3.45% absolute reduction from baseline has *never* occurred non-crisis; would require sustained quarterly mean of −$30B (vs. structural +$46B) # Directional lean per outcome - **Yes (spending drops ≥$250B)**: Supporting — OBBBA cuts deepen 2026-2028; some discretionary freezes possible; Kalshi price has risen sharply (+8.5% in 7 days). Opposing — Spending is currently $432B *above* baseline and rising; DOGE ended with minimal verified savings; mandatory spending structurally growing $150-200B/year; historical precedent essentially nonexistent outside crises. - **No**: Strongly supported by all FRED data, historical precedent, DOGE failure, and structural mandatory-spending dynamics. # Gaps / unknowns - What drove the +8.5% Kalshi price spike in 7 days? (Possible OBBBA implementation news or debt ceiling dynamics) - Whether a severe recession before 2028 could sharply cut transfer payment *disbursements* (unlikely to reduce FGEXPND definitionally) - FGEXPND data for Q2–Q4 2026 and beyond not yet available # Calibration anchors - **Kalshi current YES price: 13.00%** (anchor — recently risen from ~4.5% low) - Structural/Monte Carlo baseline: ~1.7–5% without aggressive policy shift - Current trajectory: spending $432B above baseline as of Q1 2026 — would require a ~$682B reversal from current level, not merely $250B from Q4 2024 - No non-crisis historical precedent for required magnitude of cut - **Assessment**: Kalshi at 13% appears generous given hard data; fair value closer to 5–8%, acknowledging residual tail risk from OBBBA ramp-up and unknown policy shocks through 2028

1. Both forecasters discount the Kalshi price spike too aggressively without identifying its cause. The brief explicitly flags an unexplained +8.5% 7-day move (from a 4.5% low to 13%) as a potential new bullish signal, yet neither forecaster investigates what drove it — possible OBBBA implementation news or debt ceiling dynamics could represent genuine new information that justifies some upward revision beyond pure structural analysis. 2. Both forecasters frame the required reversal as ~$682B from current levels, which is correct but insufficiently emphasized as the dominant constraint. The brief states FGEXPND must fall to ≤$6,997.7B from a current $7,679.7B — a drop of roughly 9% from current trajectory — making this far harder than the headline "$250B below Q4 2024" framing implies, and both rationales could stress this more to justify placing fair value even below 6-7%. 3. Neither forecaster adequately addresses the recession tail risk scenario. The brief notes that a severe recession before 2028 is theoretically possible but quickly dismisses it ("unlikely to reduce FGEXPND definitionally"), yet COVID demonstrated a crisis can cause $250B+ swings; both forecasters assign this scenario near-zero implicit weight without explaining why a recession would fail to reduce FGEXPND when it has done so historically. 4. Both forecasters anchor closely on the Monte Carlo baseline of ~1.7% but then roughly triple it without fully justifying the multiplier. The brief's own assessment suggests 5–8% fair value, yet neither forecaster explains the specific scenarios (OBBBA ramp + recession + discretionary freeze coinciding) that would bridge from 1.7% to their chosen 6–7%, leaving the calibration somewhat arbitrary. 5. The OBBBA's CBO-projected $840B Medicaid cuts over 10 years are treated as a minor tail factor, but neither forecaster explicitly calculates whether accelerated front-loading could plausibly contribute to a single-quarter reading below threshold by late 2027–2028; given work requirements begin December 2026, a rough annualized run-rate check (~$84B/year average, concentrated post-2027) would help bound this scenario more precisely.

6% (65% confidence)

Yes: 6% No: 94%

Spending is currently $432B above the Q4 2024 baseline and rising, requiring a ~$682B reversal to hit threshold — a magnitude never seen outside COVID crises. Monte Carlo baseline is ~1.7%, DOGE ended with minimal verified savings, and OBBBA cuts ramp too slowly and are offset by mandatory spending growth. The Kalshi 13% appears generous relative to hard data; I set fair value at 6%, leaving a modest tail for recession/OBBBA acceleration shocks.

Total pipeline time: 141.1s